Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial
- PMID: 27914903
- PMCID: PMC5285447
- DOI: 10.1016/S2215-0366(16)30378-9
Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial
Erratum in
-
Correction: Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicenter, pragmatic, observer-blind, randomized controlled superiority trial.Lancet Psychiatry. 2017 Aug;4(8):582. doi: 10.1016/S2215-0366(17)30283-3. Lancet Psychiatry. 2017. PMID: 28748793 Free PMC article. No abstract available.
Abstract
Background: Psychological treatments for adolescents with unipolar major depressive disorder are associated with diagnostic remission within 28 weeks in 65-70% of patients. We aimed to assess the medium-term effects and costs of psychological therapies on maintenance of reduced depression symptoms 12 months after treatment.
Methods: We did this multicentre, pragmatic, observer-blind, randomised controlled superiority trial (IMPACT) at 15 National Health Service child and adolescent mental health service (CAMHS) clinics in three regions in England. Adolescent patients (aged 11-17 years) with a diagnosis of DSM IV major depressive disorder were randomly assigned (1:1:1), via a web-based randomisation service, to receive cognitive behavioural therapy (CBT) or short-term psychoanalytical therapy versus a reference brief psychological intervention. Randomisation was stochastically minimised by age, sex, self-reported depression sum score, and region. Patients and clinicians were aware of group allocation, but allocation was concealed from outcome assessors. Patients were followed up and reassessed at weeks 6, 12, 36, 52, and 86 post-randomisation. The primary outcome was self-reported depression symptoms at weeks 36, 52, and 86, as measured with the self-reported Mood and Feelings Questionnaire (MFQ). Because our aim was to compare the two psychological therapies with the brief psychosocial intervention, we first established whether CBT was inferior to short-term psychoanalytical psychotherapy for the same outcome. Primary analysis was by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN83033550.
Findings: Between June 29, 2010, and Jan 17, 2013, we randomly assigned 470 patients to receive the brief psychosocial intervention (n=158), CBT (n=155), or short-term psychoanalytical therapy (n=157); 465 patients comprised the intention-to-treat population. 392 (84%) patients had available data for primary analysis by the end of follow-up. Treatment fidelity and differentiation were established between the three interventions. The median number of treatment sessions differed significantly between patients in the brief psychosocial intervention group (n=6 [IQR 4-11]), CBT group (n=9 [5-14]), and short-term psychoanalytical therapy group (n=11 [5-23]; p<0·0001), but there was no difference between groups in the average duration of treatment (27·5 [SD 21·5], 24·9 [17·7], 27·9 [16·8] weeks, respectively; Kruskal-Wallis p=0·238). Self-reported depression symptoms did not differ significantly between patients given CBT and those given short-term psychoanalytical therapy at weeks 36 (treatment effect 0·179, 95% CI -3·731 to 4·088; p=0·929), 52 (0·307, -3·161 to 3·774; p=0·862), or 86 (0·578, -2·948 to 4·104; p=0·748). These two psychological treatments had no superiority effect compared with brief psychosocial intervention at weeks 36 (treatment effect -3·234, 95% CI -6·611 to 0·143; p=0·061), 52 (-2·806, -5·790 to 0·177; p=0·065), or 86 (-1·898, -4·922 to 1·126; p=0·219). Physical adverse events (self-reported breathing problems, sleep disturbances, drowsiness or tiredness, nausea, sweating, and being restless or overactive) did not differ between the groups. Total costs of the trial interventions did not differ significantly between treatment groups.
Interpretation: We found no evidence for the superiority of CBT or short-term psychoanalytical therapy compared with a brief psychosocial intervention in maintenance of reduced depression symptoms 12 months after treatment. Short-term psychoanalytical therapy was as effective as CBT and, together with brief psychosocial intervention, offers additional patient choice for psychological therapy, alongside CBT, for adolescents with moderate to severe depression who are attending routine specialist CAMHS clinics.
Funding: National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme, and the Department of Health.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license. Published by Elsevier Ltd.. All rights reserved.
Figures

Comment in
-
From efficacy to pragmatic trials: does the dodo bird verdict apply?Lancet Psychiatry. 2017 Feb;4(2):84-85. doi: 10.1016/S2215-0366(16)30404-7. Epub 2016 Dec 1. Lancet Psychiatry. 2017. PMID: 27914904 No abstract available.
-
Hunting down an evidence base for adolescent mental health.Lancet Psychiatry. 2017 Feb;4(2):83. doi: 10.1016/S2215-0366(16)30443-6. Epub 2017 Jan 12. Lancet Psychiatry. 2017. PMID: 28089312 No abstract available.
-
The IMPACT trial - Authors' reply.Lancet Psychiatry. 2017 Apr;4(4):275-276. doi: 10.1016/S2215-0366(17)30086-X. Lancet Psychiatry. 2017. PMID: 28347429 No abstract available.
-
The IMPACT trial.Lancet Psychiatry. 2017 Apr;4(4):275. doi: 10.1016/S2215-0366(17)30087-1. Lancet Psychiatry. 2017. PMID: 28347430 No abstract available.
Similar articles
-
Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.Health Technol Assess. 2017 Mar;21(12):1-94. doi: 10.3310/hta21120. Health Technol Assess. 2017. PMID: 28394249 Free PMC article. Clinical Trial.
-
Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.Lancet Psychiatry. 2021 Jun;8(6):487-499. doi: 10.1016/S2215-0366(21)00083-3. Epub 2021 May 14. Lancet Psychiatry. 2021. PMID: 34000240 Clinical Trial.
-
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.Health Technol Assess. 2017 Aug;21(46):1-366. doi: 10.3310/hta21460. Health Technol Assess. 2017. PMID: 28857042 Free PMC article. Clinical Trial.
-
Psychosocial interventions for preventing and treating depression in dialysis patients.Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD004542. doi: 10.1002/14651858.CD004542.pub3. Cochrane Database Syst Rev. 2019. PMID: 31789430 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
Cited by
-
Reward-related predictors of symptom change in behavioral activation therapy for anhedonic adolescents: a multimodal approach.Neuropsychopharmacology. 2023 Mar;48(4):623-632. doi: 10.1038/s41386-022-01481-4. Epub 2022 Oct 28. Neuropsychopharmacology. 2023. PMID: 36307561 Free PMC article.
-
'It's always difficult when it's family. . . whereas when you're talking to a therapist. . .': Parents' views of cognitive-behaviour therapy for depressed adolescents.Clin Child Psychol Psychiatry. 2021 Oct;26(4):1018-1034. doi: 10.1177/13591045211013846. Epub 2021 May 19. Clin Child Psychol Psychiatry. 2021. PMID: 34011197 Free PMC article.
-
A video-feedback parenting intervention to prevent enduring behaviour problems in at-risk children aged 12-36 months: the Healthy Start, Happy Start RCT.Health Technol Assess. 2021 May;25(29):1-84. doi: 10.3310/hta25290. Health Technol Assess. 2021. PMID: 34018919 Free PMC article. Clinical Trial.
-
The effect of systematic couple group therapy on families with depressed juveniles: a pilot trial.Front Psychiatry. 2024 May 28;15:1283519. doi: 10.3389/fpsyt.2024.1283519. eCollection 2024. Front Psychiatry. 2024. PMID: 38863609 Free PMC article.
-
What contributes to good outcomes? The perspective of young people on short-term psychoanalytic psychotherapy for depressed adolescents.PLoS One. 2021 Sep 24;16(9):e0257334. doi: 10.1371/journal.pone.0257334. eCollection 2021. PLoS One. 2021. PMID: 34559829 Free PMC article.
References
-
- Whiteford HA, Degenhardt L, Rehm J. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–1586. - PubMed
-
- March J, Silva S, Petrycki S. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292:807–820. - PubMed
-
- Rush AJ, Wisniewski SR, Zisook S. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. Psychol Med. 2012;42:1131–1149. - PubMed
-
- National Institute for Health and Care Excellence . CG28: depression in children and young people: identification and management in primary, community and secondary care. National Institute for Health and Care Excellence; London: 2005. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources